Omega Fund Management »

Alumis shares owned by Omega Fund Management

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.7M 653k 13.30

More positions owned by Omega Fund Management

Nuvation Bio Common Stock Class A (NUVB)
Lexeo Therapeutics Common Stock (LXEO)
Replimune Group Common Stock (REPL)
enGene Holdings Common Stock (ENGN)
Alumis Common Stock (ALMS)
Morphic Holding Common Stock (MORF)
Sana Biotechnology Common Stock (SANA)
Ikena Oncology Common Stock (IKNA)
Immunic Common Stock (IMUX)
Syros Pharmaceuticals Common Stock (SYRS)
enGene Holdings Warrant (ENGNW)

View all positions for Omega Fund Management

Top funds holding Alumis

AyurMaya Capital Management Company
Foresite Capital Management V
Samsara BioCapital
venBio Partners
Cormorant Asset Management
Sr One Capital Management
Baker Bros. Advisors
Nextech Invest
BlackRock
Omega Fund Management
Tang Capital Management
TowerView
Morgan Stanley
Geode Capital Management
Iron Triangle Partners

View all funds holding Alumis